Ovarian autoimmunity and ovarian pathologies: Antigenic targets and diagnostic significance;Auto-immunité anti-ovarienne et pathologies ovariennes: Cibles antigéniques et implications diagnostiques

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 34, Issue 7 I, 2005, Pages 649-657

  Monnier Barbarino, P ^a   Forges, T ^a   Faure, G C ^b   Bene M C ^b  

^a Maternite Regionale Universitaire   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Auto immunity; Infertility; Ovarian antigens; Premature ovarian failure

Indexed keywords

GONADOTROPIN;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNE SYSTEM; IMMUNIZATION; INFERTILITY; NONHUMAN; OVARY DISEASE; OVARY INSUFFICIENCY; PREMATURE OVARIAN FAILURE; REPRODUCTION; REVIEW; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; ZONA PELLUCIDA;

EID: 33244474850     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0368-2315(05)82897-2     Document Type: Review

References (76)

1. Vallotton MB, Forbes AP. Antibodies to cytoplasm of ova. Lancet 1966; 2: 264-5.
2. Fenichel P, Sosset C, Barbarino-Monnier P, Gobert B, Hieronimus S, Bene MC et al. Prevalence, specificity and significance of ovarian antibodies during spontaneous premature ovarian failure. Hum Reprod 1997; 12: 2623-8.
3. Luborsky JL, Visintin I, Boyers S, Asari T, Caldwell B, DeCherney A. Ovarian antibodies detected by immobilized antigen immunoassay in patients with premature ovarian failure. J Clin Endocrinol Metab 1990; 70: 69-75.
4. Wheatcroft NJ, Toogood AA, Li TC, Cooke ID, Weetman AP. Detection of antibodies to ovarian antigens in women with premature ovarian failure. Clin Exp Immunol 1994; 96: 122-8.
5. Wheatcroft NJ, Salt C, Milford-Ward A, Cooke ID, Weetman AP. Identification of ovarian antibodies by immunofluorescence, enzyme-linked immunosorbent assay or immunoblotting in premature ovarian failure. Hum Reprod 1997; 12: 2617-22.
6. Coulam CB. The prevalence of autoimmune disorders among patients with primary ovarian failure. Am J Reprod Immunol 1983; 4: 63-6.
7. Perheentupa J. APS-I/APECED: the clinical disease and therapy. Endocrinol Metab Clin North Am 2002; 31: 295-320.
8. Horejsi J, Novakova D, Martinek J. Circulating ovarian autoantibodies and FSH and LH levels in adolescent girls with primary menstrual cycle disorders. J Pediatr Adolesc Gynecol 1996; 9: 74-8.
9. Cameron IT, O'Shea FC, Rolland JM, Hughes EG, de Kretser DM, Healy DL. Occult ovarian failure: a syndrome of infertility, regular menses, and elevated follicle-stimulating hormone concentrations. J Clin Endocrinol Metab 1988; 67: 1190-4.
10. Ahmed Ebbiary NA, Lenton EA, Salt C, Ward AM, Cooke ID. The significance of elevated basal follicle stimulating hormone in regularly menstruating infertile women. Hum Reprod 1994; 9: 245-52.
11. Luborsky J, Llanes B, Davies S, Binor Z, Radwanska E, Pong R. Ovarian autoimmunity: greater frequency of autoantibodies in premature menopause and unexplained infertility than in the general population. Clin Immunol 1999; 90: 368-74.
12. Luborsky J, Llanes B, Roussev R, Coulam C. Ovarian antibodies, FSH and inhibin B: independent markers associated with unexplained infertility. Hum Reprod 2000; 15: 1046-51.
13. van Gelderen CJ, Gomes dos Santos ML. Polycystic ovarian syndrome. Evidence for an autoimmune mechanism in some cases. J Reprod Med 1993; 38: 381-6.
14. Fenichel P, Gobert B, Carre Y, Barbarino-Monnier P, Hieronimus S. Polycystic ovary syndrome in autoimmune disease. Lancet 1999; 353: 2210.
15. Rojansky N, Roll D, Meirow D. Polycystic ovary syndrome. An autoimmune disease? J Reprod Med 1997; 42: 325-8.
16. Luborsky JL, Shatavi S, Adamczyk P, Chiong C, Llanes B, Lafniztzegger J et al. Polycystic ovary syndrome and ovarian autoimmunity: assessment of ovarian antibodies by EIA. J Reprod Immunol 1999; 42: 79-84.
17. Gleicher N, el-Roeiy A, Confino E, Friberg J. Is endometriosis an autoimmune disease? Obstet Gynecol 1987; 70: 115-22.
18. Szczepanska M, Skrzypczak J, Kurpisz M. Evaluation of autoantibodies against oocyte theca cells in peritoneal effusion and serum of women with endometriosis. Ginekol Pol 1997; 68: 588-95.
19. Meyer WR, Lavy G, DeCherney AH, Visintin I, Economy K, Luborsky JL. Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol 1990; 75: 795-9.
20. Luborsky JL, Thiruppathi P, Rivnay B, Roussev R, Coulam C, Radwanska E. Evidence for different aetiologies of low estradiol response to FSH: age-related accelerated luteinization of follicles or presence of ovarian autoantibodies. Hum Reprod 2002; 17: 2641-9.
21. Narayanan M, Murthy PS, Munaf SA, Shah LC, Kini MD. Antiovarian antibodies and their effect on the outcome of assisted reproduction. J Assist Reprod Genet 1995; 12: 599-605.
22. Moustafa M, Ozornek MH, Krussel JS, Cupisti S, Bodden-Heidrich R, Koldovsky U et al. The effect of antigamete antibodies on the success of assisted reproduction. Clin Exp Obstet Gynecol 1997; 24: 67-9.
23. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, Bene MC, Landes P, Faure G. Antiovary antibodies, repeated attempts, and outcome of in vitro fertilization. Fertil Steril 1991; 56: 928-32.
24. Geva E, Vardinon N, Lessing JB, Lerner-Geva L, Azem F, Yovel I et al. Organ-specific autoantibodies are possible markers for reproductive failure: a prospective study in an in-vitro fertilization-embryo transfer programme. Hum Reprod 1996; 11: 1627-31.
25. Luborsky J, Pong R. Pregnancy outcome and ovarian antibodies in infertility patients undergoing controlled ovarian hyperstimulation. Am J Reprod Immunol 2000; 44: 261-5.
26. Barbarino-Monnier P, Gobert B, Guillet-Rosso F, Béné MC, Foliguet B, Heymes O et al. Auto-immunité et fécondation in vitro: effets des multiponctions sur la prévalence des anticorps anti-ovaires. Contracept Fertil Sex 1990; 18: 627-8.
27. Moncayo H, Moncayo R, Benz R, Wolf A, Lauritzen C. Ovarian failure and autoimmunity. Detection of autoantibodies directed against both the unoccupied luteinizing hormone/human chorionic gonadotropin receptor and the hormone-receptor complex of bovine corpus luteum. J Clin Invest 1989; 84: 1857-65.
28. Gobert B, Barbarino-Monnier P, Guillet-May F, Bene MC, Faure GC. Anti-ovary antibodies after attempts at human in vitro fertilization induced by follicular puncture rather than hormonal stimulation. J Reprod Fertil 1992; 96: 213-8.
29. Monnier-Barbarino P, Jouan C, Dubois M, Gobert B, Faure G, Bene MC. Anti-ovarian antibodies and in vitro fertilization: cause or consequence? Gynecol Obstet Fertil 2003; 31: 770-3.
30. Anderson JR, Goudie RB, Gray K, Stuart-Smith DA. Immunological features of idiopathic Addison's disease: an antibody to cells producing steroid hormones. Clin Exp Immunol 1968; 3: 107-17.
31. Irvine WJ, Chan MM, Scarth L, Kolb FO, Hartog M, Bayliss RI et al. Immunological aspects of premature ovarian failure associated with idiopathic Addison's disease. Lancet 1968; 2: 883-7.
32. Sotsiou F, Bottazzo GF, Doniach D. Immunofluorescence studies on autoantibodies to steroid-producing cells, and to germline cells in endocrine disease and infertility. Clin Exp Immunol 1980; 39: 97-111.
33. Betterle C, Rossi A, Dalla Pria S, Artifoni A, Pedini B, Gavasso S et al. Premature ovarian failure: autoimmunity and natural history. Clin Endocrinol (Oxf) 1993; 39: 35-43.
34. Falorni A, Laureti S, Santeusanio F. Autoantibodies in autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002; 31: 369-89.
35. Dal Pra C, Chen S, Furmaniak J, Smith BR, Pedini B, Moscon A et al. Autoantibodies to steroidogenic enzymes in patients with premature ovarian failure with and without Addison's disease. Eur J Endocrinol 2003; 148: 565-70.
36. Ahonen P, Miettinen A, Perheentupa J. Adrenal and steroidal cell antibodies in patients with autoimmune polyglandular disease type I and risk of adrenocortical and ovarian failure. J Clin Endocrinol Metab 1987; 64: 494-500.
37. Falorni A, Laureti S, Candeloro P, Perrino S, Coronella C, Bizzarro A et al. Steroid-cell autoantibodies are preferentially expressed in women with premature ovarian failure who have adrenal autoimmunity. Fertil Steril 2002; 78: 270-9.
38. Hoek A, Schoemaker J, Drexhage HA. Premature ovarian failure and ovarian autoimmunity. Endocr Rev 1997; 18: 107-34.
39. Arif S, Vallian S, Farzaneh F, Zanone MM, James SL, Pietropaolo M et al. Identification of 3 beta-hydroxysteroid dehydrogenase as a novel target of steroid cell autoantibodies: association of autoantibodies with endocrine autoimmune disease. J Clin Endocrinol Metab 1996; 81: 4439-45.
40. Reimand K, Peterson P, Hyoty H, Uibo R, Cooke I, Weetman AP et al. 3beta-hydroxysteroid dehydrogenase autoantibodies are rare in premature ovarian failure. J Clin Endocrinol Metab 2000; 85: 2324-6.
41. Chiauzzi V, Cigorraga S, Escobar ME, Rivarola MA, Charreau EH. Inhibition of follicle-stimulating hormone receptor binding by circulating immunoglobulins. J Clin Endocrinol Metab 1982; 54: 1221-8.
42. Chiauzzi VA, Bussmann L, Calvo JC, Sundblad V, Charreau EH. Circulating immunoglobulins that inhibit the binding of follicle-stimulating hormone to its receptor: a putative diagnostic role in resistant ovary syndrome? Clin Endocrinol (Oxf) 2004; 61: 46-54.
43. Austin GE, Coulam CB, Ryan RJ. A search for antibodies to luteinizing hormone receptors in premature ovarian failure. Mayo Clin Proc 1979; 54: 394-400.
44. van Weissenbruch MM, Hoek A, van Vliet-Bleeker I, Schoemaker J, Drexhage H. Evidence for existence of immunoglobulins that block ovarian granulosa cell growth in vitro. A putative role in resistant ovary syndrome? J Clin Endocrinol Metab 1991; 73: 360-7.
45. Tilly JL, Aihara T, Nishimori K, Jia XC, Billig H, Kowalski KI et al. Expression of recombinant human follicle-stimulating hormone receptor: species-specific ligand binding, signal transduction, and identification of multiple ovarian messenger ribonucleic acid transcripts. Endocrinology 1992; 131: 799-806.
46. Anasti JN, Flack MR, Froehlich J, Nelson LM. The use of human recombinant gonadotropin receptors to search for immunoglobulin G-mediated premature ovarian failure. J Clin Endocrinol Metab 1995; 80: 824-8.
47. Westhoff WE, Slootstra JW, Puijk WC, van Leeuwen L, Schaaper WM, Oonk HB et al. In vitro inhibition of the biological activity of follicle-stimulating hormone by anti-peptide antisera representing the human follicle-stimulating hormone beta subunit sequence 33-53. Biol Reprod 1997; 56: 460-8.
48. Ferro VA, Stimson WH. Fertility-disrupting potential of synthetic peptides derived from the beta-subunit of follicle-stimulating hormone. Am J Reprod Immunol 1998; 40: 187-97.
49. Herve V, Roy F, Bertin J, Guillou F, Maurel MC. Antiequine chorionic gonadotropin (eCG) antibodies generated in goats treated with eCG for the induction of ovulation modulate the luteinizing hormone and follicle-stimulating hormone bioactivities of eCG differently. Endocrinology 2004; 145: 294-303.
50. McLaughlin EA, Holland MK, Aitken RJ. Contraceptive vaccines. Expert Opin Biol Ther 2003; 3: 829-41.
51. Pala A, Coghi I, Spampinato G, Di Gregorio R, Strom R, Carenza L. Immunochemical and biological characteristics of a human autoantibody to human chorionic gonadotropin and luteinizing hormone. J Clin Endocrinol Metab 1988; 67: 1317-21.
52. Amato F, Warnes GM, Kirby CA, Norman RJ. Infertility caused by HCG autoantibody. J Clin Endocrinol Metab 2002; 87: 993-7.
53. Gobert B, Jolivet-Reynaud C, Dalbon P, Barbarino-Monnier P, Faure GC, Jolivet M et al. An immunoreactive peptide of the FSH involved in autoimmune infertility. Biochem Biophys Res Commun 2001; 289: 819-24.
54. Santa-Coloma TA, Crabb JW, Reichert LE, Jr. Serine analogues of hFSH-beta-(33-53) and hFSH-beta-(81-95) inhibit hFSH binding to receptor. Biochem Biophys Res Commun 1992; 184: 1273-9.
55. Pasoto SG, Viana VS, Mendonca BB, Yoshinari NH, Bonfa E. Anti-corpus luteum antibody: a novel serological marker for ovarian dysfunction in systemic lupus erythematosus? J Rheumatol 1999; 26: 1087-93.
56. Mori T, Nishimoto T, Kitagawa M, Noda Y, Nishimura T, Oikawa T. Possible presence of autoantibodies to zone pellucida in infertile women. Experientia 1978; 34: 797-9.
57. Shivers CA, Dunbar BS. Autoantibodies to zona pellucida: a possible cause for infertility in women. Science 1977; 197: 1082-4.
58. Sacco AG, Moghissi KS. Anti-zona pellucida activity in human sera. Fertil Steril 1979; 31: 503-6.
59. Mori T, Nishimoto T, Kohda H, Takai I, Nishimura T, Oikawa T. A method for specific detection of autoantibodies to the zona pellucida in infertile women. Fertil Steril 1979; 32: 67-72.
60. Van Voorhis BJ, Stovall DW. Autoantibodies and infertility: a review of the literature. J Reprod Immunol 1997; 33: 239-56.
61. Kamada M, Daitoh T, Mori K, Maeda N, Hirano K, Irahara M et al. Etiological implication of autoantibodies to zona pellucida in human female infertility. Am J Reprod Immunol 1992; 28: 104-9.
62. Dunbar BS, Prasad S, Carino C, Skinner SM. The ovary as an immune target. J Soc Gynecol Investig 2001; 8: S43-8.
63. Ulcova-Gallova Z, Bouse V, Svabek L, Turek J, Rokyta Z. Endometriosis in reproductive immunology. Am J Reprod Immunol 2002; 47: 269-74.
64. Caudle MR, Shivers CA, Wild RA. Clinical significance of naturally occurring anti-zona pellucida antibodies in infertile women. Am J Reprod Immunol Microbiol 1987; 15: 119-21.
65. Hovav Y, Almagor M, Benbenishti D, Margalioth EJ, Kafka I, Yaffe H. Immunity to zona pellucida in women with low response to ovarian stimulation, in unexplained infertility and after multiple IVF attempts. Hum Reprod 1994; 9: 643-5.
66. Mantzavinos T, Dalamanga N, Hassiakos D, Dimitriadou F, Konidaris S, Zourlas PA. Assessment of autoantibodies to the zona pellucida in serum and follicular fluid in in-vitro fertilization patients. Clin Exp Obstet Gynecol 1993; 20: 111-5.
67. Papale ML, Grillo A, Leonardi E, Giuffrida G, Palumbo M, Palumbo G. Assessment of the relevance of zona pellucida antibodies in follicular fluid of in-vitro fertilization (IVF) patients. Hum Reprod 1994; 9: 1827-31.
68. Horejsi J, Martinek J, Novakova D, Madar J, Brandejska M. Autoimmune antiovarian antibodies and their impact on the success of an IVF/ET program. Ann N Y Acad Sci 2000; 900: 351-6.
69. Mardesic T, Ulcova-Gallova Z, Huttelova R, Muller P, Voboril J, Mikova M et al. The influence of different types of antibodies on in vitro fertilization results. Am J Reprod Immunol 2000; 43: 1-5.
70. Damewood MD, Zacur HA, Hoffman GJ, Rock JA. Circulating antiovarian antibodies in premature ovarian failure. Obstet Gynecol 1986; 68: 850-4.
71. Tong ZB, Nelson LM. A mouse gene encoding an oocyte antigen associated with autoimmune premature ovarian failure. Endocrinology 1999; 140: 3720-6.
72. Tong ZB, Nelson LM, Dean J. Mater encodes a maternal protein in mice with a leucine-rich repeat domain homologous to porcine ribonuclease inhibitor. Mamm Genome 2000; 11: 281-7.
73. Nelson LM. Autoimmune ovarian failure: comparing the mouse model and the human disease. J Soc Gynecol Investig 2001; 8: S55-7.
74. Tong ZB, Gold L, De Pol A, Vanevski K, Dorward H, Sena P et al. Developmental expression and subcellular localization of mouse MATER, an oocyte-specific protein essential for early development. Endocrinology 2004; 145: 1427-34.
75. Tong ZB, Bondy CA, Zhou J, Nelson LM. A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum Reprod 2002; 17: 903-11.
76. Lou Y, Tung KS. T cell peptide of a self-protein elicits autoantibody to the protein antigen. Implications for specificity and pathogenetic role of antibody in autoimmunity. J Immunol 1993; 151: 5790-9.